Short Interest in Aurora Cannabis Inc. (NASDAQ:ACB) Expands By 6.8%

Aurora Cannabis Inc. (NASDAQ:ACB) was the recipient of a large growth in short interest in October. As of October 31st, there was short interest totalling 2,810,000 shares, a growth of 6.8% from the October 15th total of 2,630,000 shares. Currently, 5.2% of the shares of the stock are short sold. Based on an average trading volume of 1,030,000 shares, the days-to-cover ratio is currently 2.7 days.

Aurora Cannabis Trading Down 3.2 %

Shares of ACB opened at $4.20 on Monday. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.83 and a quick ratio of 1.88. Aurora Cannabis has a 1-year low of $2.84 and a 1-year high of $9.35. The stock has a market cap of $230.33 million, a price-to-earnings ratio of -5.53 and a beta of 1.87. The firm has a 50 day simple moving average of $5.52 and a 200-day simple moving average of $5.87.

Hedge Funds Weigh In On Aurora Cannabis

Several hedge funds have recently bought and sold shares of ACB. Cubist Systematic Strategies LLC acquired a new stake in shares of Aurora Cannabis during the 2nd quarter worth about $50,000. Mackenzie Financial Corp purchased a new stake in Aurora Cannabis in the 2nd quarter worth approximately $113,000. Toronto Dominion Bank grew its stake in Aurora Cannabis by 34,356.4% in the 2nd quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock worth $88,000 after acquiring an additional 18,896 shares during the period. Headlands Technologies LLC raised its holdings in Aurora Cannabis by 98.8% in the 2nd quarter. Headlands Technologies LLC now owns 74,988 shares of the company’s stock valued at $346,000 after acquiring an additional 37,269 shares during the last quarter. Finally, TD Asset Management Inc purchased a new position in shares of Aurora Cannabis during the 2nd quarter worth $255,000. Hedge funds and other institutional investors own 47.63% of the company’s stock.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.